- Archive
Eli Lilly Looks To Enter Oncology Market With New Partner
After signing an elaborate research partnership in April with France's Sanofi SA to codevelop and comarket the oncology drug oxaliplatin in the U.S., Eli Lilly is eager to magnify its presence in the oncology market, Garry Nicholson, director of the ...